Comparative proteomic investigation of metastatic and non-metastatic osteosarcoma cells of human and canine origin
Open Access
- 14 September 2017
- journal article
- research article
- Published by Public Library of Science (PLoS) in PLOS ONE
- Vol. 12 (9) , e0183930
Abstract
Osteosarcoma is the most common bone cancer in dogs and people. In order to improve clinical outcomes, it is necessary to identify proteins that are differentially expressed by metastatic cells. Membrane bound proteins are responsible for multiple pro-metastatic functions. Therefore characterizing the differential expression of membranous proteins between metastatic and non-metastatic clonal variants will allow the discovery of druggable targets and consequently improve treatment methodology. The objective of this investigation was to systemically identify the membrane-associated proteomics of metastatic and non-metastatic variants of human and canine origin. Two clonal variants of divergent in vivo metastatic potential from human and canine origins were used. The plasma membranes were isolated and peptide fingerprinting was used to identify differentially expressed proteins. Selected proteins were further validated using western blotting, flow cytometry, confocal microscopy and immunohistochemistry. Over 500 proteins were identified for each cell line with nearly 40% of the proteins differentially regulated. Conserved between both species, metastatic variants demonstrated significant differences in expression of membrane proteins that are responsible for pro-metastatic functions. Additionally, CD147, CD44 and vimentin were validated using various biochemical techniques. Taken together, through a comparative proteomic approach we have identified several differentially expressed cell membrane proteins that will help in the development of future therapeutics.Keywords
This publication has 55 references indexed in Scilit:
- Camouflage and sabotage: tumor escape from the immune systemCancer Immunology, Immunotherapy, 2011
- Membrane proteomic analysis of pancreatic cancer cellsJournal of Biomedical Science, 2010
- Plasma Membrane Proteomics and Its Application in Clinical Cancer Biomarker DiscoveryMolecular & Cellular Proteomics, 2010
- Reversible Ponceau staining as a loading control alternative to actin in Western blotsAnalytical Biochemistry, 2010
- Comparative proteomic analysis of plasma membrane proteins between human osteosarcoma and normal osteoblastic cell linesBMC Cancer, 2010
- Vimentin Is a Novel Anti-Cancer Therapeutic Target; Insights from In Vitro and In Vivo Mice Xenograft StudiesPLOS ONE, 2010
- Canine tumor cross-species genomics uncovers targets linked to osteosarcoma progressionBMC Genomics, 2009
- Collagen density promotes mammary tumor initiation and progressionBMC Medicine, 2008
- Targeting RAS signalling pathways in cancer therapyNature Reviews Cancer, 2003
- Integrins: Versatility, modulation, and signaling in cell adhesionCell, 1992